Allicin protects against cisplatin-induced vestibular dysfunction by inhibiting the apoptotic pathway.

Allicin protects against cisplatin-induced vestibular dysfunction by inhibiting the apoptotic pathway.

Eur J Pharmacol. 2017 Mar 01;:

Authors: Wu X, Cai J, Li X, Li H, Li J, Bai X, Liu W, Han Y, Xu L, Zhang D, Wang H, Fan Z

Abstract
Cisplatin is an anticancer drug that causes the impairment of inner ear function as side effects, including hearing loss and balance dysfunction. The purpose of this study was to investigate the effects of allicin against cisplatin-induced vestibular dysfunction in mice and to make clear the mechanism underlying the protective effects of allicin on oto-vestibulotoxicity. Mice intraperitoneally injected with cisplatin exhibited vestibular dysfunction in swimming test, which agreed with impairment in vestibule. However, these impairments were significantly prevented by pre-treatment with allicin. Allicin markedly reduced cisplatin-activated expression of cleaved-caspase-3 in hair cells and vascular layer cells of utricule, saccule and ampulla, but also decreased AIF nuclear translocation of hair cells in utricule, saccule and ampulla. These results showed that allicin played an effective role in protecting vestibular dysfunction induced by cisplatin via inhibiting caspase-dependent and caspase-independent apoptotic pathways. Therefore, allicin may be useful in preventing oto-vestibulotoxicity mediated by cisplatin.

PMID: 28259711 [PubMed - as supplied by publisher]

http://ift.tt/2maH1n1